New study shows abbott's blood test for concussion could predict outcomes from brain injury and inform treatment interventions

The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (tbi), providing important information to determine appropriate care researchers used abbott's i-stat™ tbi plasma test – the only fda-cleared rapid test on a portable analyzer for concussion – and abbott's core laboratory architect instrument to measure two biomarkers in blood plasma associated with brain injury abbott park, ill., aug. 11, 2022 /prnewswire/ -- a new study published in the lancet neurology demonstrates the ability of two blood-based biomarkers to predict how someone will recover from traumatic brain injury (tbi).
ABT Ratings Summary
ABT Quant Ranking